TARSUS PHARMACEUTICALS, INC. TARS 深 滬
等待開盤 08-20 09:30:00 美东时间
53.70
-0.910
-1.67%
華盛通- 最 高55.00
- 今 開54.31
- 成交量 39.17万股
- 最 低 53.66
- 昨 收 54.61
- 總市值 22.56亿
- 52周最高 57.28
- 市盈率 靜 --
- 換手率 0.93%
- 52周最低 25.82
- 委 比 81.77%
- 總股本 4201.42万
- 歷史最高 63.69
- 量 比 0.54
- 振 幅 2.45%
- 歷史最低 10.80
- 每 手 1
- 風險率 7.47%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Tarsus targets 95,000–100,000 bottles for Q3 2025 amid accelerated XDEMVY launch momentum
Earnings Call Insights: Tarsus Pharmaceuticals (TARS) Q2 2025 Management View CEO Bobak R. Azamian highlighted that "we delivered record-breaking results of more than $100 million in net sales and app...
08-07 15:04
Tarsus Pharmaceuticals Reports Record Sales Growth
Tarsus Pharmaceuticals, Inc. ( ($TARS) ) has released its Q2 earnings. Here is ...
08-07 12:54
Earnings Scheduled For August 6, 2025
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
Tarsus Pharmaceuticals, Inc. will host a live webcast on August 6, 2025, at 1:30 p.m. PT / 4:30 p.m. ET, to discuss its second quarter 2025 financial results and provide a corporate update. Participants can access the webcast via the provided link. A recorded version will be available on the company's website for 90 days. Tarsus focuses on advancing treatments for eye care and infectious diseases, with FDA-approved XDEMVY® for Demodex blepharitis...
07-30 21:00
多轮破亿元资金注入人形机器人赛道，资本更青睐“汽车人”造“人”？
本报（chinatimes.net.cn）记者于建平 见习记者 黄蓓 北京报道 在汽车企业掌门人们还在为确保现金流充足，不断降本增效的同时，另一群从汽车产业出走...
07-23 21:05
豪掷21亿，「天才少年」抢了宇树风头？
原标题：豪掷21亿，「天才少年」抢了宇树风头？ 来源：凤凰网 7月8日深夜，国内具身智能赛道悄悄流出了一个重要消息——智元机器人计划通过协议转让和要约收购的方...
07-10 11:00
具身智能机器人公司它石智航完成1.22亿美元天使+轮融资，美团战投领投
7月8日，国内具身智能机器人创业公司它石智航（TARS）宣布完成1.22亿美元天使+轮融资。本轮融资由美团战投领投，钧山投资、碧鸿投资、国汽投资、临港科创投、赛...
07-08 17:40
万字回顾首届中国AI算力大会！15+位大咖主会场演讲精华爆棚，来没来都值得收藏
原标题：万字回顾首届中国AI算力大会！15+位大咖主会场演讲精华爆棚，来没来都值得收藏 来源：投资界综合 6月26日，一场干货爆棚的AI算力盛会，在北京灿烂盛...
07-04 14:03
Tarsus to Participate in Upcoming Investor Conferences
Tarsus Pharmaceuticals announced that its management will attend three upcoming investor conferences: the William Blair 45th Annual Growth Stock Conference on June 3rd, the Jefferies Global Healthcare Conference on June 4th, and the Goldman Sachs 46th Annual Global Healthcare Conference on June 9th. Live webcasts and additional details are available on the company's website, with replays archived within 48 hours. Tarsus focuses on advancing treat...
05-29 21:00
美股大行评级 | 潜在涨幅1562.13%！Cingulate获Ascendiant Capital升目标价至61美元，维持"买入"评级
潜在涨幅1562.13%！Cingulate获Ascendiant Capital升目标价至61美元，维持"买入"评级
05-28 09:04
